| Literature DB >> 29914879 |
Rachel Ann Spencer1, Simon Edward Frank Spencer2, Sarah Rodgers3, Stephen M Campbell4, Anthony John Avery3.
Abstract
BACKGROUND: There is a need for greater understanding of the epidemiology of primary care patient safety in order to generate solutions to prevent future harm. AIM: To estimate the rate of failures in processing actions requested in hospital discharge summaries, and to determine factors associated with these failures. DESIGN ANDEntities:
Keywords: care transition; general practice; patient discharge; patient safety
Mesh:
Year: 2018 PMID: 29914879 PMCID: PMC6058631 DOI: 10.3399/bjgp18X697877
Source DB: PubMed Journal: Br J Gen Pract ISSN: 0960-1643 Impact factor: 5.386
Study practice characteristics
| 10 | Nottingham | 8800 | 5 | Yes | 39.5 | 1760 | SystmOne | 90.3 | Outstanding |
| 11 | Nottingham | 12 900 | 6 | Yes | 33.6 | 1355 | SystmOne | 94.3 | Good |
| 12 | Nottingham | 13 300 | 10 | Yes | 7 | 2484 | SystmOne | 99.9 | Outstanding |
| 13 | Nottingham | 7300 | 3 | Yes | 43.7 | 2440 | EMIS Web | 96 | Good |
| 14 | Nottingham | 7400 | 6 | No | 50.2 | 1476 | SystmOne | 93.2 | Good |
| 15 | Coventry | 4600 | 7 | Yes | 44.7 | 1314 | EMIS Web | 91.2 | Requires improvement |
| 16 | Coventry | 6400 | 6 | Yes | 38.2 | 1600 | SystmOne | 97.3 | Good |
| 17 | Nottingham | 9500 | 9 | No | 23.4 | 1727 | SystmOne | 93.9 | Good |
| 18 | Manchester | 5600 | 5 | Yes | 33.4 | 1251 | EMIS Web | 99.7 | Good |
| 19 | Manchester | 21 700 | 1 | Yes | 40.5 | 2281 | EMIS Web | 98.9 | Good |
Practice list sizes rounded to nearest 100 to preserve anonymity.
Based on 2015–2016 practice profiles: https://fingertips.phe.org.uk/profile/general-practice.
From CQC interactive map: http://www.cqc.org.uk/content/doctorsgps. CQC = Care Quality Commission. EMIS = Egton Medical Information Systems. QOF = Quality and Outcomes Framework. WTE = whole-time equivalent.
Modelling of overall failure to complete actions
| 0.444 | ||||||
| 1.10 | 0.34 to 3.60 | 0.875 | ||||
| 1.1 | 0.34 to3.60 | 0.875 | ||||
| 1.03 | 0.32 to 3.35 | 0.959 | ||||
| 1.36 | 0.40 to 4.70 | 0.624 | ||||
| 3.64 | 1.04 to 12.78 | 0.044 | ||||
| 1.50 | 0.46 to 4.88 | 0.501 | ||||
| 1.18 | 0.36 to 3.89 | 0.787 | ||||
| 1.27 | 0.38 to 4.22 | 0.698 | ||||
| 0.75 | 0.23 to 2.49 | 0.639 | ||||
| 1.00 | 0.99 to 1.01 | 0.939 | ||||
| 0.03 | 0.03 to 1.14 | 0.253 | ||||
| 1.01 | 0.99 to 1.02 | 0.503 | ||||
| 1.23 | 0.58 to 2.59 | 0.587 | ||||
| 1.00 | 1.00 to 1.00 | 0.098 | 1.00 | 1.00 to 1.00 | 0.693 | |
| 0.022 | 0.417 | |||||
| 0.33 | 0.13 to 0.85 | 0.022 | 0.40 | 0.10 to 1.61 | 0.195 | |
| 0.27 | 0.10 to 0.72 | 0.009 | 0.35 | 0.07 to 1.76 | 0.203 | |
| 1.11 | 0.67 to 1.85 | 0.685 | ||||
| 0.99 | 0.52 to 1.89 | 0.985 | ||||
| 1.01 | 0.99 to 1.03 | 0.490 | ||||
| 1.16 | 0.51 to 2.63 | 0.728 | ||||
| 0.95 | 0.88 to 1.03 | 0.192 | ||||
| 1.62 | 0.99 to 2.65 | 0.053 | 0.98 | 0.45 to 2.12 | 0.962 | |
| 1.03 | 0.98 to 1.07 | 0.257 | ||||
| 1.40 | 0.84 to 2.33 | 0.191 | ||||
| 1.12 | 1.01 to 1.25 | 0.028 | 1.14 | 1.02 to 1.27 | 0.0216 | |
| 0.100 | 0.631 | |||||
| 0.67 | 0.33 to 1.40 | 0.288 | 0.68 | 0.31 to 1.51 | 0.345 | |
| 1.89 | 0.97 to 3.65 | 0.060 | 1.22 | 0.49 to 3.05 | 0.664 | |
| 1.30 | 0.49 to 3.48 | 0.601 | 1.30 | 0.47 to 3.58 | 0.616 | |
| 0.95 | 0.57 to 1.60 | 0.854 | ||||
ANOVA P-values are from a likelihood ratio test, the remainder are Wald P-values.
CQC rating was converted to a numeric scale for all analyses (1 = outstanding, 2 = good, 3 = requires improvement) in order to model this variable. ANOVA = analysis of variance. CQC = Care Quality Commission. EMIS = Egton Medical Information Systems. IMD = index of multiple deprivation. OR = odds ratio. QMC = Queen’s Medical Centre. QOF = Quality and Outcomes Framework.
Modelling of failure to complete medications changes
| <0.001 | <0.001 | |||||
| 9.77 | 5.26 to 18.15 | <0.001 | 8.55 | 4.30 to 16.99 | <0.001 | |
| 4.93 | 1.47 to 16.58 | 0.010 | 4.16 | 1.15 to 15.06 | 0.030 | |
| 6.66 | 3.38 to 13.12 | <0.001 | 7.41 | 3.56 to 15.44 | <0.001 | |
| 1.93 | 0.61 to 6.08 | 0.264 | 1.39 | 0.42 to 4.62 | 0.590 | |
| 5.92 | 1.47 to 23.78 | 0.012 | 3.40 | 0.68 to 17.01 | 0.136 | |
| 3.29 | 1.32 to 8.18 | 0.010 | 2.06 | 0.77 to 5.52 | 0.150 | |
| 6.58 | 1.22 to 35.37 | 0.028 | 5.58 | 0.98 to 31.76 | 0.053 | |
| 8.13 | 2.93 to 22.57 | <0.001 | 7.41 | 2.31 to 23.78 | 0.001 | |
| 7.18 | 2.04 to 25.21 | 0.002 | 8.88 | 2.32 to 34.01 | 0.001 | |
| <0.001 | 0.025 | |||||
| 0.25 | 0.14 to 0.46 | <0.001 | 0.40 | 0.20 to 0.81 | 0.011 | |
| 0.70 | 0.40 to 1.21 | 0.201 | 0.81 | 0.41 to 1.61 | 0.553 | |
| 1.71 | 1.08 to 2.68 | 0.021 | 1.64 | 0.92 to 2.91 | 0.094 | |
| 0.043 | ||||||
| 0.77 | 0.31 to 1.88 | 0.563 | ||||
| 1.18 | 0.47 to 2.93 | 0.722 | ||||
| 0.83 | 0.33 to 2.07 | 0.686 | ||||
| 1.32 | 0.54 to 3.25 | 0.547 | ||||
| 2.04 | 0.87 to 4.81 | 0.103 | ||||
| 1.29 | 0.53 to 3.18 | 0.574 | ||||
| 0.87 | 0.35 to 2.15 | 0.767 | ||||
| 0.63 | 0.24 to 1.66 | 0.351 | ||||
| 0.40 | 0.14 to 1.18 | 0.097 | ||||
| 0.99 | 0.98 to 1.00 | 0.011 | 0.99 | 0.98 to 1.00 | 0.150 | |
| 1.11 | 0.84 to 1.47 | 0.473 | ||||
| 1.01 | 1.00 to 1.01 | 0.023 | 1.01 | 1.00 to 1.02 | 0.003 | |
| 2.28 | 1.33 to 3.92 | 0.003 | 1.70 | 0.88 to 3.29 | 0.117 | |
| 1.00 | 1.00 to 1.00 | 0.235 | ||||
| 0.011 | 0.240 | |||||
| 0.47 | 0.26 to 0.84 | 0.011 | 0.52 | 0.16 to 1.68 | 0.274 | |
| 0.37 | 0.19 to 0.69 | 0.002 | 0.32 | 0.08 to 1.39 | 0.130 | |
| 0.85 | 0.57 to 1.26 | 0.415 | ||||
| 0.90 | 0.56 to 1.43 | 0.648 | ||||
| 1.00 | 0.99 to 1.02 | 0.608 | ||||
| 0.81 | 0.43 to 1.53 | 0.508 | ||||
| 0.93 | 0.88 to 0.99 | 0.033 | 1.00 | 0.90 to 1.12 | 0.962 | |
| 1.29 | 0.88 to 1.90 | 0.198 | ||||
| 1.01 | 0.98 to 1.05 | 0.411 | ||||
| 0.93 | 0.63 to 1.37 | 0.715 | ||||
| 0.85 | 0.78 to 0.92 | <0.001 | 0.86 | 0.77 to 0.95 | 0.004 | |
| 0.001 | 0.339 | |||||
| 0.56 | 0.30 to 1.06 | 0.073 | 0.68 | 0.29 to 1.61 | 0.381 | |
| 1.69 | 1.06 to 2.69 | 0.029 | 1.07 | 0.46 to 2.51 | 0.868 | |
| 0.36 | 0.13 to 1.03 | 0.058 | 0.38 | 0.11 to 1.32 | 0.129 | |
| 1.21 | 0.81 to 1.80 | 0.361 | ||||
ANOVA P-values are from a likelihood ratio test, the remainder are Wald P-values.
For example, Fortisip.
Practice variable not included in multivariate model due to confounding with practice size and QOF score. ANOVA = analysis of variance. BNF = British National Formulary. CQC = Care Quality Commission. EMIS = Egton Medical Information Systems. IMD = index of multiple deprivation. OR = odds ratio. QMC = Queen’s Medical Centre. QOF = Quality and Outcomes Framework.
Modelling of failure to complete tests
| 0.262 | ||||||
| 2.62 | 0.73 to 9.44 | 0.141 | ||||
| 2.20 | 0.47 to 10.27 | 0.316 | ||||
| 0.77 | 0.30 to 2.02 | 0.601 | ||||
| 1.01 | 0.99 to 1.04 | 0.363 | ||||
| 0.99 | 0.91 to 1.07 | 0.720 | ||||
| 1.18 | 0.21 to 6.55 | 0.849 | ||||
| 1.00 | 1.00 to 1.00 | 0.952 | ||||
| 2.98 | 1.12 to 7.91 | 0.029 | 3.67 | 1.30 to 10.35 | 0.014 | |
| 2.64 | 0.70 to 9.92 | 0.151 | ||||
| 0.210 | ||||||
| 0.41 | 0.11 to 1.55 | 0.190 | ||||
| 0.24 | 0.05 to 1.19 | 0.081 | ||||
| 1.03 | 0.99 to 1.08 | 0.193 | ||||
| 2.98 | 0.35 to 25.25 | 0.316 | ||||
| 0.97 | 0.84 to 1.11 | 0.640 | ||||
| 1.69 | 0.71 to 4.02 | 0.235 | ||||
| 2.30 | 0.87 to 6.07 | 0.091 | 2.95 | 1.04 to 8.36 | 0.042 | |
| 0.89 | 0.74 to 1.08 | 0.240 | ||||
| 0.189 | ||||||
| 3.33 | 0.84 to 13.17 | 0.086 | ||||
| 2.40 | 0.70 to 8.18 | 0.162 | ||||
| 0.73 | 0.14 to 3.82 | 0.707 | ||||
| 2.06 | 0.76 to 5.57 | 0.154 | ||||
ANOVA P-values are from a likelihood ratio test, the remainder are Wald P-values. ANOVA = analysis of variance. CQC = Care Quality Commission. EMIS = EMIS = Egton Medical Information Systems. IMD = index of multiple deprivation. OR = odds ratio. QMC = Queen’s Medical Centre. QOF = Quality and Outcomes Framework.
Summary of harm measures and their weighted Cohen’s kappas19
| Severity | 1–4 | 0.8 (good) | 0.65 to 0.95 | |
| Severity | 1–5 | 0.58 (moderate) | 0.28 to 0.88 | |
| Preventability | 1–6 | 0.50 (moderate) | 0.1 to 0.89 |
NES = NHS Education Scotland. WHO = World Health Organization.
| Senna | 17 | |
| Macrogols | 14 | |
| Docusate | 5 | |
| Lactulose | 2 | |
| Fybogel (ispaghula husk) | 2 | |
|
| ||
| Paracetamol | 15 | |
| Oral morphine | 4 | |
| Ibuprofen | 2 | |
| Oxycodone preparations | 2 | |
| Zopiclone | 2 | |
|
| ||
|
| ||
| Bisoprolol | 3 | |
| Angiotensin converting enzyme inhibitors | 3 | |
| Amlodipine | 2 | |
| Furosemide | 2 | |
|
| ||
| Ulcer healing drugs | 5 | |
| Alginates | 4 | |
|
| ||
| Calcium supplements | 3 | |
| Alendronate | 2 | |
| Cholecalciferol | 2 | |
|
| ||
|
| ||
| Carbocisteine | 2 | |
| Inhaled corticosteroids | 2 | |
|
| ||
| Ferrous fumarate | 2 | |
CNS = central nervous system.
| Multiple common tests or non-specific request for bloods | 6 | |
| Urea and electrolytes | 5 | |
| Other, full blood count, digoxin levels, prostate specific antigen, folate | 4 | |
|
| ||
| Chest X-Ray for resolution of pneumonia | 3 | |
| Dual-energy X-ray absorptiometry scan | 1 | |
| Cardiac echo | 1 | |
|
| ||
| Pulmonary function testing | 1 | |
| 24-hour electrocardiogram | 1 | |
| Electroencephalogram | 1 | |